Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The EMBRACE Registry: European Post-Market Registry for Catheter Based Mitral Valve Replacement

NCT07409285 is registered in ClinicalTrials.gov with HighLife SAS as lead sponsor.

NCT NCT07409285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07409285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The EMBRACE Registry: European Post-Market Registry for Catheter Based Mitral Valve Replacement
Lead sponsor
HighLife SAS
Phase
Observational
Overall status
Not yet recruiting
Start date
March 14, 2026
Completion date
April 15, 2031
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation